Menu
Back to User profile » Dr Wenxian Wang
Papers published by Dr Wenxian Wang:
Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer
Xu YB, Zhang Y, Song Z, Wang W, Shao L
Cancer Management and Research 2021, 13:6309-6317
Published Date: 10 August 2021
FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib
Ying X, Tu J, Wang W, Li X, Xu C, Ji J
OncoTargets and Therapy 2019, 12:9303-9307
Published Date: 6 November 2019
The efficacy and safety of anlotinib treatment for advanced lung cancer
Shao L, Wang W, Song Z, Zhang Y
OncoTargets and Therapy 2019, 12:6549-6554
Published Date: 15 August 2019
Intestinal metastasis from primary ROS1-positive lung adenocarcinoma cancer patients responding to crizotinib
Chen HF, Zhang QX, Zhu YC, Du KQ, Li XF, Wu LX, Wang WX, Xu CW
OncoTargets and Therapy 2018, 11:7821-7825
Published Date: 5 November 2018
Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report
Zhu Y, Liao X, Wang W, Xu C, Zhuang W, Zhong L, Du K, Chen Y, Chen G, Fang M
OncoTargets and Therapy 2017, 10:3187-3192
Published Date: 27 June 2017
Patients harboring EGFR mutation after primary resistance to crizotinib and response to EGFR-tyrosine kinase inhibitor
Wang WX, Jiang XW, Song ZB, Zhang YP
OncoTargets and Therapy 2016, 9:211-215
Published Date: 8 January 2016